secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2026-05-22T20:10:16+00:00
Accession:  0001690585-26-000026
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus stockholders elect directors, approve say-on-pay, ratify Deloitte at 2026 annual meeting
--------------------------------------------------------------------------------

- Sujay Kango, Anne McGeorge, and Jonathan Violin elected Class II directors with 42.7M, 34.8M, and 42.8M votes for, respectively.
- Advisory vote on executive compensation passed: 41.0M for, 1.7M against, 0.5M abstain, 3.6M broker non-votes.
- Ratification of Deloitte & Touche as auditor for 2026 approved: 46.3M for, 5.3K against, 0.5M abstain, no broker non-votes.
- All three proposals passed with substantial majorities; no material changes to governance disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/0001690585-26-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/dnth-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001690585-26-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer